試す金 - 無料

Bio Spectrum - BioSpectrum India Oct 2024

Magzter GOLDで無制限に

読む Bio Spectrum 9,500以上の雑誌や新聞を1回の定期購読で購読できます

カタログを見る

1ヶ月

$14.99

1年 $149.99

$149.99

$12/month

(OR)

Bio Spectrumのみを購読する

贈り物 Bio Spectrum

いつでもキャンセルできます。

(義務なし) ⓘ

定期購読にご満足いただけない場合は、定期購読開始日から 7 日以内に help@magzter.com までメールをお送りいただければ、全額返金いたします。質問は一切ありません。お約束します! (注: 単号購入には適用されません)

デジタルサブスクリプション

即時アクセス ⓘ

今すぐ購読すると、Magzter の Web サイト、iOS、Android、Amazon アプリですぐに読み始めることができます。

安全性を確認済み

支払い ⓘ

Magzter は Authorize.Net の認定販売業者です。詳細はこちら

この号では

BHARAT EYES GLOBAL BIOMANUFACTURING DOMINANCE: Boosting Innovation, Collaboration & Entrepreneurship with BioE3 Policy Bharat has demonstrated a strong economic growth in the past decade and is poised to be amongst the global leaders in the next industrial revolution by leveraging emerging technologies and new innovative solutions. Bharat is competitively positioned to be amongst the global leaders in futuristic manufacturing that leverages living systems. Biomanufacturing can fundamentally transform the global economy from today’s consumptive manufacturing paradigm to the one based on regenerative principles. Biomanufacturing refers to the use of engineered microbial, plant, and animal (including human) cells with increasing precision and control to produce commercially important products on scale. These are versatile processes that have the potential to create bio-based products allowing efficient utilisation of resources, in a scalable and costeffective manner with reduced environmental impact. Keeping in view the national priority of steering Bharat on the path of accelerated ‘Green Growth’, an integrated BioE3 (Biotechnology for Economy, Environment and Employment) Policy for “Fostering High-Performance Biomanufacturing” with an aim to make a green, clean, prosperous, and self-reliant Bharat was released on September 12 at Global Bio-India (GBI) 2024.

Centre launches National Strategy For Prevention of Unintentional Injury

The Ministry of Health and Family Welfare, Government of India and World Health Organization (WHO) released India's National Strategy For Prevention of Unintentional Injury at #Safety2024: 15th World Conference on Injury Prevention and Safety Promotion on September 2 in New Delhi.

1 mins

Health Minister introduces National Medical Register Portal of National Medical Commission

Union Minister for Health & Family Welfare, Jagat Prakash Nadda recently inaugurated the National Medical Register (NMR) Portal of the National Medical Commission (NMC) for registration of all the MBBS doctors who are eligible for registration in India, in presence of Union Minister of State (MoS) for Health & Family Welfare, Anupriya Patel and virtual presence of Union MoS for Health & Family Welfare, Prataprao Jadhav.

1 mins

Cambrian Bioworks raises $1.45 M to transform molecular diagnostics in India

Bengaluru-based biotechnology startup Cambrian Bioworks has secured $1.45 million in seed funding.

1 mins

Vipragen, Zumutor form strategic alliance in biologics CRO sector

Bengaluru-based companies Vipragen Biosciences and Zumutor Biologics have announced a strategic partnership to set up an endto-end Biologics Contract Research Organisation (CRO) platform to support discovery, clone to preclinical development of biologics/biosimilars.

1 mins

Pristyn Care partners with CureMyKnee to establish CoE for joint replacement surgeries

Gurugram-based startup Pristyn Care, a leading healthcare provider specialising in advanced secondary care surgeries, is establishing a Centre for Excellence (CoE) in Joint Replacement Surgeries with Cure My Knee.

1 mins

Skye Air Mobility partners with CARITAS Hospital for drone-based medical deliveries in Kottayam

New Delhi-based startup Skye Air Mobility, a leading drone technology-based logistics firm, has announced a collaboration with CARiTAS Hospital & Institute of Health Sciences, Kottayam, Kerala, to revolutionise medical deliveries through drone technology.

1 mins

BHARAT EYES GLOBAL BIOMANUFACTURING DOMINANCE: Boosting Innovation, Collaboration & Entrepreneurship with BioE3 Policy

Bharat has demonstrated a strong economic growth in the past decade and is poised to be amongst the global leaders in the next industrial revolution by leveraging emerging technologies and new innovative solutions.

10+ mins

Can phased trade margin rationalisation boost pharma growth?

The pharma representatives of the Laghu Udyog Bharati (LUB), an RSS affiliate and a not-forprofit Pan India Organisation with the aim of empowering Micro and Small enterprises in the country since its formation in 1994, on July 24, had a meeting with officials from the Department of Pharmaceuticals, and discussed key issues such as Trade Margin Rationalisation (TMR), Schedule-M extension, Revised PTUS Hurdles, and the Drug Tribunal Board formation. LUB Pharma proposed the innovative \"One Nation-One Molecule-One MRP\" and advocated for the top 100 companies to sell their generic brands at molecule name and affordable Maximum Retail Price (MRP) for patient benefits. Here we are looking at a series of recommendations from industry associations to make TMR more effective, balanced, and supportive of all stakeholders in the pharmaceutical supply chain.

4 mins

TELANGANA WAGES WAR AGAINST COUNTERFEIT DRUGS

Telangana contributes nearly one-third to India’s production and one-fifth to its exports in the pharmaceutical sector.

5 mins

Why industry-academia collaboration is crucial for biomedical sciences

India's growing biomedical sciences sector is ripe with potential, yet it faces several challenges. In recent years, there has been a notable shift in government policies, private investments, and educational reforms aimed at boosting research and innovation in this critical area. One of the key factors that can significantly influence this growth is the collaboration between industry and academia. Such partnerships have the power to not only fuel the biomedical sector but also strengthen India's position as a global player in healthcare research and innovation.

4 mins

Bharat BioEconomy to touch.$30 trillion by 2050: IBER 2024

“The Indian BioEconomy is projected to rise to $30 trillion by 2050, within a global economy valued at $228 trillion, representing a significant increase in its economic share from 4 to 13 per cent,” according to the India BioEconomy Report (IBER 2024), prepared for 'Make In India Facilitation Cell for Biotechnology' of Biotechnology Industry Research Assistance Council (BIRAC), by Association of Biotechnology Led Enterprises (ABLE).

3 mins

Meril expands healthcare education network with opening of Satellite Academy in Kochi

Meril, a global medical technology and education leader, has expanded its healthcare education network by launching the Meril Satellite Academy in Kerala’s port city, Kochi.

1 mins

Amit Mookim steps in as CEO of Immuneel Therapeutics

Bengaluru-based Immuneel Therapeutics, a pioneering cell and gene therapy platform, has announced the appointment of Amit Mookim as its new Chief Executive Officer (CEO).

1 mins

Study reveals role of Ayurvedic Whole System in management of Rheumatoid Arthritis

A new scientific study has revealed the significant effectiveness of the Ayurvedic Whole System (AWS) in the management of Rheumatoid Arthritis (RA), a chronic autoimmune disorder affecting millions worldwide.

1 mins

"Bridge the gap and accelerate India's advancements in innovative therapies"

Dr Ramesh Mundlamuri has over 19 years of experience in various biopharmaceutical organizations and has ample experience in various divisions and sections of the biopharmaceutical industry, including Research & Development, Technology Transfer, Commercial Manufacturing, Product & Process Development, Operations Management and so on.

6 mins

すべてのストーリーを読む Bio Spectrum

Bio Spectrum Description:

出版社: MM-Activ-Sci-Tech-Communication

カテゴリ: Business

言語: English

頻度: Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.